The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Contrast-Enhanced Ultrasound Market Research Report 2025
Synopsis
Contrast-Enhanced Ultrasound also known as CEUS, is an ultrasound which use gas filled micro bubbles for the improved visualize blood vessels and organs in the pelvis and abdomen regions such as liver, spleen pancreas, bowel, kidney and bladder.
The global Contrast-Enhanced Ultrasound market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Contrast-Enhanced Ultrasound is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Contrast-Enhanced Ultrasound is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Contrast-Enhanced Ultrasound in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Contrast-Enhanced Ultrasound include Trivitron Healthcare, Bracco Diagnostic Inc., Koninklijke Philips N.V., BK Medical Holding Company, Inc., Lantheus Medical Imaging, Inc., GE Healthcare, Daiichi Sankyo Company, Limited, Bristol-Myers Squibb Company and Acusphere, Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Contrast-Enhanced Ultrasound, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contrast-Enhanced Ultrasound.
Report Scope
The Contrast-Enhanced Ultrasound market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contrast-Enhanced Ultrasound market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contrast-Enhanced Ultrasound companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Trivitron Healthcare
Bracco Diagnostic Inc.
Koninklijke Philips N.V.
BK Medical Holding Company, Inc.
Lantheus Medical Imaging, Inc.
GE Healthcare
Daiichi Sankyo Company, Limited
Bristol-Myers Squibb Company
Acusphere, Inc
Segment by Type
Non-targeted contrast-enhanced ultrasound
Targeted contrast-enhanced ultrasound
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Contrast-Enhanced Ultrasound companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Contrast-Enhanced Ultrasound also known as CEUS, is an ultrasound which use gas filled micro bubbles for the improved visualize blood vessels and organs in the pelvis and abdomen regions such as liver, spleen pancreas, bowel, kidney and bladder.
The global Contrast-Enhanced Ultrasound market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Contrast-Enhanced Ultrasound is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Contrast-Enhanced Ultrasound is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Contrast-Enhanced Ultrasound in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Contrast-Enhanced Ultrasound include Trivitron Healthcare, Bracco Diagnostic Inc., Koninklijke Philips N.V., BK Medical Holding Company, Inc., Lantheus Medical Imaging, Inc., GE Healthcare, Daiichi Sankyo Company, Limited, Bristol-Myers Squibb Company and Acusphere, Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Contrast-Enhanced Ultrasound, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contrast-Enhanced Ultrasound.
Report Scope
The Contrast-Enhanced Ultrasound market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contrast-Enhanced Ultrasound market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contrast-Enhanced Ultrasound companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Trivitron Healthcare
Bracco Diagnostic Inc.
Koninklijke Philips N.V.
BK Medical Holding Company, Inc.
Lantheus Medical Imaging, Inc.
GE Healthcare
Daiichi Sankyo Company, Limited
Bristol-Myers Squibb Company
Acusphere, Inc
Segment by Type
Non-targeted contrast-enhanced ultrasound
Targeted contrast-enhanced ultrasound
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Contrast-Enhanced Ultrasound companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Contrast-Enhanced Ultrasound Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Non-targeted contrast-enhanced ultrasound
1.2.3 Targeted contrast-enhanced ultrasound
1.3 Market by Application
1.3.1 Global Contrast-Enhanced Ultrasound Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Contrast-Enhanced Ultrasound Market Perspective (2019-2030)
2.2 Contrast-Enhanced Ultrasound Growth Trends by Region
2.2.1 Global Contrast-Enhanced Ultrasound Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Contrast-Enhanced Ultrasound Historic Market Size by Region (2019-2024)
2.2.3 Contrast-Enhanced Ultrasound Forecasted Market Size by Region (2025-2030)
2.3 Contrast-Enhanced Ultrasound Market Dynamics
2.3.1 Contrast-Enhanced Ultrasound Industry Trends
2.3.2 Contrast-Enhanced Ultrasound Market Drivers
2.3.3 Contrast-Enhanced Ultrasound Market Challenges
2.3.4 Contrast-Enhanced Ultrasound Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Contrast-Enhanced Ultrasound Players by Revenue
3.1.1 Global Top Contrast-Enhanced Ultrasound Players by Revenue (2019-2024)
3.1.2 Global Contrast-Enhanced Ultrasound Revenue Market Share by Players (2019-2024)
3.2 Global Contrast-Enhanced Ultrasound Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Contrast-Enhanced Ultrasound Revenue
3.4 Global Contrast-Enhanced Ultrasound Market Concentration Ratio
3.4.1 Global Contrast-Enhanced Ultrasound Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Contrast-Enhanced Ultrasound Revenue in 2023
3.5 Contrast-Enhanced Ultrasound Key Players Head office and Area Served
3.6 Key Players Contrast-Enhanced Ultrasound Product Solution and Service
3.7 Date of Enter into Contrast-Enhanced Ultrasound Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Contrast-Enhanced Ultrasound Breakdown Data by Type
4.1 Global Contrast-Enhanced Ultrasound Historic Market Size by Type (2019-2024)
4.2 Global Contrast-Enhanced Ultrasound Forecasted Market Size by Type (2025-2030)
5 Contrast-Enhanced Ultrasound Breakdown Data by Application
5.1 Global Contrast-Enhanced Ultrasound Historic Market Size by Application (2019-2024)
5.2 Global Contrast-Enhanced Ultrasound Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Contrast-Enhanced Ultrasound Market Size (2019-2030)
6.2 North America Contrast-Enhanced Ultrasound Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Contrast-Enhanced Ultrasound Market Size by Country (2019-2024)
6.4 North America Contrast-Enhanced Ultrasound Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Contrast-Enhanced Ultrasound Market Size (2019-2030)
7.2 Europe Contrast-Enhanced Ultrasound Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Contrast-Enhanced Ultrasound Market Size by Country (2019-2024)
7.4 Europe Contrast-Enhanced Ultrasound Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Contrast-Enhanced Ultrasound Market Size (2019-2030)
8.2 Asia-Pacific Contrast-Enhanced Ultrasound Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Contrast-Enhanced Ultrasound Market Size by Region (2019-2024)
8.4 Asia-Pacific Contrast-Enhanced Ultrasound Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Contrast-Enhanced Ultrasound Market Size (2019-2030)
9.2 Latin America Contrast-Enhanced Ultrasound Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Contrast-Enhanced Ultrasound Market Size by Country (2019-2024)
9.4 Latin America Contrast-Enhanced Ultrasound Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Contrast-Enhanced Ultrasound Market Size (2019-2030)
10.2 Middle East & Africa Contrast-Enhanced Ultrasound Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Contrast-Enhanced Ultrasound Market Size by Country (2019-2024)
10.4 Middle East & Africa Contrast-Enhanced Ultrasound Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Trivitron Healthcare
11.1.1 Trivitron Healthcare Company Detail
11.1.2 Trivitron Healthcare Business Overview
11.1.3 Trivitron Healthcare Contrast-Enhanced Ultrasound Introduction
11.1.4 Trivitron Healthcare Revenue in Contrast-Enhanced Ultrasound Business (2019-2024)
11.1.5 Trivitron Healthcare Recent Development
11.2 Bracco Diagnostic Inc.
11.2.1 Bracco Diagnostic Inc. Company Detail
11.2.2 Bracco Diagnostic Inc. Business Overview
11.2.3 Bracco Diagnostic Inc. Contrast-Enhanced Ultrasound Introduction
11.2.4 Bracco Diagnostic Inc. Revenue in Contrast-Enhanced Ultrasound Business (2019-2024)
11.2.5 Bracco Diagnostic Inc. Recent Development
11.3 Koninklijke Philips N.V.
11.3.1 Koninklijke Philips N.V. Company Detail
11.3.2 Koninklijke Philips N.V. Business Overview
11.3.3 Koninklijke Philips N.V. Contrast-Enhanced Ultrasound Introduction
11.3.4 Koninklijke Philips N.V. Revenue in Contrast-Enhanced Ultrasound Business (2019-2024)
11.3.5 Koninklijke Philips N.V. Recent Development
11.4 BK Medical Holding Company, Inc.
11.4.1 BK Medical Holding Company, Inc. Company Detail
11.4.2 BK Medical Holding Company, Inc. Business Overview
11.4.3 BK Medical Holding Company, Inc. Contrast-Enhanced Ultrasound Introduction
11.4.4 BK Medical Holding Company, Inc. Revenue in Contrast-Enhanced Ultrasound Business (2019-2024)
11.4.5 BK Medical Holding Company, Inc. Recent Development
11.5 Lantheus Medical Imaging, Inc.
11.5.1 Lantheus Medical Imaging, Inc. Company Detail
11.5.2 Lantheus Medical Imaging, Inc. Business Overview
11.5.3 Lantheus Medical Imaging, Inc. Contrast-Enhanced Ultrasound Introduction
11.5.4 Lantheus Medical Imaging, Inc. Revenue in Contrast-Enhanced Ultrasound Business (2019-2024)
11.5.5 Lantheus Medical Imaging, Inc. Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Detail
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Contrast-Enhanced Ultrasound Introduction
11.6.4 GE Healthcare Revenue in Contrast-Enhanced Ultrasound Business (2019-2024)
11.6.5 GE Healthcare Recent Development
11.7 Daiichi Sankyo Company, Limited
11.7.1 Daiichi Sankyo Company, Limited Company Detail
11.7.2 Daiichi Sankyo Company, Limited Business Overview
11.7.3 Daiichi Sankyo Company, Limited Contrast-Enhanced Ultrasound Introduction
11.7.4 Daiichi Sankyo Company, Limited Revenue in Contrast-Enhanced Ultrasound Business (2019-2024)
11.7.5 Daiichi Sankyo Company, Limited Recent Development
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Company Detail
11.8.2 Bristol-Myers Squibb Company Business Overview
11.8.3 Bristol-Myers Squibb Company Contrast-Enhanced Ultrasound Introduction
11.8.4 Bristol-Myers Squibb Company Revenue in Contrast-Enhanced Ultrasound Business (2019-2024)
11.8.5 Bristol-Myers Squibb Company Recent Development
11.9 Acusphere, Inc
11.9.1 Acusphere, Inc Company Detail
11.9.2 Acusphere, Inc Business Overview
11.9.3 Acusphere, Inc Contrast-Enhanced Ultrasound Introduction
11.9.4 Acusphere, Inc Revenue in Contrast-Enhanced Ultrasound Business (2019-2024)
11.9.5 Acusphere, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
